Clinical Trial: A Study of Olomorasib (LY3537982) in Healthy Participants

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07439250) titled 'A Study of Olomorasib (LY3537982) in Healthy Participants' on Feb. 24.

Brief Summary: The main purpose of this study in healthy participants is to determine the effect of fluconazole on the amount of study drug that gets into the bloodstream and how long it takes the body to get rid of it. For each participant, the study will last up to approximately 7 weeks and will require 12 overnight stays in the research center.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Olomorasib

Administered orally

DRUG: Fluconazole

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Spon...